- Home
- Equipment
- canada quebec
- therapeutic development
Refine by
Applications
- Solutions for Endometriosis
- Solutions for Severe but Non-Specific Symptoms
- Acute Kidney Injury (AKI) Device for Reduction of Galectin-3 Levels
- Acute Kidney Injury (AKI) Device for Plasmapheresis Therapy
- Acute Kidney Injury (AKI) Device for Patient Selective Apheresis
- Microbiome Therapeutics for Clinical Trials
- Medical solutions for MiniTC and mini-stem system sector
- Synthesis and machine learning driven techniques solutions for biological r&d sector
- Synthesis and machine learning driven techniques solutions for metabolic engineering industry
- Synthesis and machine learning driven techniques solutions for protein design and manufacturing industry
- Synthesis and machine learning driven techniques solutions for antibody optimization industry
- Synthesis and machine learning driven techniques solutions for vaccine development sector
- Software Solutions for Deep Mutational Scanning & Selection
- Software Solutions for COVID-19
Therapeutic Development Equipment & Supplies Near Canada Quebec
68 equipment items found
by:CrystalsFirst GmbH based inMarburg, GERMANY
FragAI is an automated workflow for generation of active molecules for therapeutics development using chemoinformatics, bioinformatics and machine learning. Our methodology uses the data flow from SmartSoak and FastForward output. The step of fragment hit expansion and evolution builds on validated fragment hits. ...
Manufactured by:Realize Therapeutics Corp. based inLake Bluff, ILLINOIS (USA)
SIBO is a condition related to excess numbers of bacteria in the small intestine, and can be linked to Irritable Bowel Syndrome, Research clearly shows that certain microbes are very effective at treating SIBO and related issues. Realize Therapeutics is developing formulas to address these health ...
Manufactured by:ASC Therapeutics based inMilpitas, CALIFORNIA (USA)
Genome editing technologies enables permanent modifications to the genome by harnessing the activities of certain enzymes (e.g. nucleases and integrase) and invoking DNA repair mechanisms at specific locations in the genome. As a therapeutic modality, genome editing can correct a defective gene, disrupt a deleterious gene, or target a therapeutic gene to a ...
by:Cyrus Biotechnology Inc. based inSeattle, WASHINGTON (USA)
Novel IL-2 approaches and technologies are driving innovation in the therapeutic development space. The IL-2 pathway influences critical aspects of both immune stimulation and immune regulation, through the development and expansion of regulatory T cells ...
by:Neoclease based inBoston, MASSACHUSETTS (USA)
Neoclease is pioneering the future of precision medicine through advanced technology in synthetic biology and generative AI. By developing synthetic nucleases, the company enhances gene editing processes to achieve unprecedented specificity and efficacy. These enzymes are meticulously crafted using proprietary algorithms powered by state-of-the-art GPT neural networks, which are ...
Manufactured by:Neutron Therapeutics, Inc. based inDanvers, MASSACHUSETTS (USA)
Neutron Therapeutics has developed an accelerator-based, in-hospital neutron source to replace the previously required nuclear reactor. This source is composed of a 2.6 MeV electrostatic proton accelerator and a rotating, solid lithium target for generating neutrons. Neutron Therapeutics will provide this neutron source as part of a comprehensive ...
by:Caribou Biosciences, Inc. based inBerkeley, CALIFORNIA (USA)
Natural killer (NK) cells, as their name implies, play an important role in ridding the body of cancer and viruses. NK cells are emerging as an increasingly important cell type for therapeutic development. Solid tumors are particularly challenging to treat and CAR-T cells have largely underperformed in the solid tumor setting. NK cells, however, inherently ...
Manufactured by:Microviable Therapeutics SL based inGijón, SPAIN
Microviable Therapeutics is developing novel technologies and next generation biotherapeutic products by harnessing the treasure of the human microbiota generating innovative solutions that enable to address unmet challenges in human ...
Manufactured by:Entero Therapeutics, Inc. based inBoca Raton, FLORIDA (USA)
Capeserod is a selective 5-HT4 receptor partial agonist, which Entero Therapeutics is repurposing and developing for multiple GI conditions. Based on the biological evidence of expression of 5-HT4b receptor subtype in human GI tract, Entero Therapeutics believes that capeserod may directly or indirectly initiate the peristaltic or secretory ...
Manufactured by:PharmAbcine Inc. based inYuseong-gu, SOUTH KOREA
PharmAbcine’s fully human antibody library provides the diversity of antibody candidates for target antigens, ensuring highest success rates of developing therapeutic antibodies for various indications. Our unique and diverse antibody repertoires are constructed by recombination of V gene segments and DJ gene segments in human B-cell derived antibody heavy ...
Manufactured by:Genscript based inPiscataway, NEW JERSEY (USA)
cPass Neutralization Antibody Detection kit detects circulating neutralizing antibodies against SARS-CoV-2 that block the interaction between the receptor binding domain (RBD) of the viral spike glycoprotein with the ACE2 cell surface receptor. This kit would be instrumental in vaccine and therapeutic development as it is suitable for all antibody isotypes and ...
Manufactured by:ProImmune Ltd. based inOxford, UNITED KINGDOM
Detecting and targeting specific MHC-peptide complexes is of material interest for understanding many disease conditions better and for developing novel therapeutic interventions. It has been very challenging to develop antibodies that bind selectively to an MHC-peptide combination over a more general MHC ...
Manufactured by:Catalent, Inc based inSomerset, NEW JERSEY (USA)
GPEx cell line development technology is a proven technology that generates high-performance, highly stable, production cell lines. Virtually any cDNA (mAb and multigenic applications) can be inserted into cells. To date, over 600 different mAb and mAb fusions and over 160+ different recombinant proteins have been produced using the GPEx system, with 160+ clinical trials ...
by:TeselaGen Biotechnology, Inc. based inPortola Valley, CALIFORNIA (USA)
Our AI-enabled Enterprise Platform radically accelerates product development of therapeutics, high value chemicals, and agricultural products. From food to pharmaceuticals, from fuels to fabrics, shorten your time to market by harnessing the full power of artificial intelligence. Start-to-Finish Solution: A single platform for design, construction, data ...
by:Zucara Therapeutics Inc. based inToronto, ONTARIO (CANADA)
Zucara Therapeutics is developing ZT-01, a first-in-class, once-daily therapeutic to prevent insulin-induced hypoglycemia in patients using insulin therapy. ZT-01 is designed to inhibit somatostatin, a pancreatic hormone that impairs the glucagon response to hypoglycemia in people with insulin dependent diabetes. ...
Manufactured by:Great Lakes NeuroTechnologies based inCleveland, OHIO (USA)
By integrating advanced technology with patient-centered design, KinesiaU™ provides objective assessments that can improve clinical outcomes by identifying optimal therapeutic activities. The development of this system by Great Lakes NeuroTechnologies emphasizes a commitment to advancing neurological ...
Manufactured by:Eliaz Therapeutics based inSanta Rosa, CALIFORNIA (USA)
Acute Kidney Injury (AKI) and sepsis are major public health concerns, with high incidence, mortality and morbidity. Despite efforts to develop new interventions, current therapeutic options are limited in scope and effectiveness. At Eliaz Therapeutics, we have developed a patented, unique medical device that will remove ...
Manufactured by:Jointechlabs Inc. based inNorth Barrington, ILLINOIS (USA)
Based on our platform and technology, Jointechlabs is developing therapies for unmet medical needs. Our first therapeutic in clinical development JTL-T-01 is a proprietary injectable stem cell scaffold as a biologic therapy for osteoarthritis, for approval under the FDA’s fast-track program. ...
by:Intellia Therapeutics, Inc. based inCambridge, MASSACHUSETTS (USA)
Our modular approach enables us to optimize the power and versatility of the CRISPR/Cas9 technology and, importantly, allows us to rapidly develop therapeutics for numerous diseases that currently have limited treatment ...
Manufactured by:Ardigen based inKraków, POLAND
Quick solution for effective immune responses in clinical trials; We have created an Artificial Intelligence platform dedicated to being a part of the therapeutic cancer vaccine development. The ArdImmune Vax platform uses sequencing data to generate and prioritize antigen targets for cancer vaccines and T-cell ...